BioClinica has added a postapproval research unit to its service offerings. The division, which the company has set up to meet rising demand for postapproval research, will make use of BioClinica's technology capabilities. Specifically, BioClinica has applied its skills to the creation of a postapproval technology platform, which is designed to simplify the research process while providing access to study metrics. Release